20229
Gel de sílice activado (20/40) 150/75 mg ORBO™ 52 pequeño, paquete de 50
W,W,F separators, O.D. × L 6 mm × 75 mm, pkg of 50 ea
Sinónimos:
ORBO™ Activated Silica Gel Tube
Iniciar sesión para ver los precios por organización y contrato.
Seleccione un Tamaño
Cambiar Vistas
Acerca de este artículo
UNSPSC Code:
47131900
NACRES:
NB.21
Servicio técnico
¿Necesita ayuda? Nuestro equipo de científicos experimentados está aquí para ayudarle.
Permítanos ayudarleQuality Level
material
W,W,F separators, silica gel
agency
NIOSH 2002,2003,2004,2005,2010,2013,2014, OSHA 16,21
product line
ORBO™
composition
Bed A, 150 mg , Bed B, 75 mg
packaging
pkg of 50 ea
manufacturer/tradename
ORBO™ 52 Small
technique(s)
active air sampling: suitable
O.D. × L
6 mm × 75 mm
matrix
Activated silica gel
particle size
20-40 mesh
application(s)
air monitoring
environmental
industrial hygiene
General description
- ORBO™ 52 Small Activated Silica Gel (20/40) 150/75 mg solvent desorption tube is designed for gas and vapor sampling.
- It contains two beds of the same selective adsorbent separated by glass wool or foam.
- Dual-layer or two-bed construction of the tube allows for any sample breakthrough to be captured in the smaller back-up bed.
Legal Information
ORBO is a trademark of Sigma-Aldrich Co. LLC
Clase de almacenamiento
11 - Combustible Solids
wgk
nwg
flash_point_f
Not applicable
flash_point_c
Not applicable
Elija entre una de las versiones más recientes:
¿Ya tiene este producto?
Encuentre la documentación para los productos que ha comprado recientemente en la Biblioteca de documentos.
H Stalsberg et al.
Virchows Archiv. A, Pathological anatomy and histopathology, 414(5), 415-422 (1989-01-01)
The autopsies of 12 victims from two snow avalanches in North-Norway are reported. Supportive evidence from non-autopsied and surviving victims is included. Consistent autopsy findings were prominent lung oedema, moderate cerebral oedema, extreme contraction of the left ventricle, petechiae in
A Orbo et al.
International journal of oncology, 5(3), 619-625 (1994-09-01)
About 50% of the cases with invasive carcinoma of the uterine cervix occurs before menopause. Cyclic changes of sex steroids may therefore interfere with the ratio between extracellular levels of cGMP and cAMP (cGMP(ex)/cAMP(ex)). This ratio has been proposed as
Anne Ørbo et al.
The Journal of steroid biochemistry and molecular biology, 113(1-2), 139-149 (2009-01-14)
Patients with endometrial hyperplasia representing preliminary stages of endometrial cancer have shown to respond to therapy in 100% of the cases when treated with levonorgestrel-impregnated intrauterine device. Anti-proliferative effect has also been reported after application of an anti-progestin impregnated intrauterine